Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest

Cardiac Arrest (CA) Clinical Trial

— Pro-ACR  

Official title:

Prognostic Factors in Refractory Cardiac Arrest Treated With Extracorporeal Life Support at Dijon CHU

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03261232
• Other study ID #: ELLOUZE 2016 Pro-ACR
• Status: Active, not recruiting
• Phase: N/A
• First received: August 23, 2017
• Last updated: August 23, 2017
• Start date: March 2016
• Est. completion date: March 2018

Study information

• Verified date: August 2017
• Source: Centre Hospitalier Universitaire Dijon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Through this retrospective observational study (over 4 years; period analysed: 1st January 2011 to 31st December 2014), we looked for prognostic factors associated with better survival in refractory cardiac arrest by:

• assessing the overall survival rate

• evaluating the frequency of intra et extra-hospital events and by comparing these with the survival rate

• studying no flow, low flow, rhythm at initial management, troponinemia, lactatemia and blood pH in the different groups.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 65
• Est. completion date: March 2018
• Est. primary completion date: March 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients with in-hospital or out-of-hospital refractory CA who underwent ECLS

Exclusion Criteria:

• CA occurring during cardiac surgery

• Age > 75 years or < 18 years

Related Conditions & MeSH terms

• Cardiac Arrest (CA)
• ExtraCorporeal Life Support (ECLS)
• Heart Arrest

Locations

Country	Name	City	State
France	CHU Dijon Bourgogne	Dijon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survival rate		at baseline
Primary	Death rate		at baseline